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Abstract
Background: Oxidative stress plays an important role in neuronal dysfunction and neuron loss in Alzheimer’s brain.
Previous studies have reported downregulation of CREB-mediated transcription by oxidative stress and Ab. The
promoter for CREB itself contains cyclic AMP response elements. Therefore, we examined the expression of CREB in
the hippocampal neurons of Tg2576 mice, AD post-mortem brain and in cultured rat hippocampal neurons
exposed to Ab aggregates.
Results: Laser Capture Microdissection of hippocampal neurons from Tg2576 mouse brain revealed decreases in
the mRNA levels of CREB and its target, BDNF. Immunohistochemical analysis of Tg2576 mouse brain showed
decreases in CREB levels in hippocampus and cortex. Markers of oxidative stress were detected in transgenic
mouse brain and decreased CREB staining was observed in regions showing abundance of astrocytes. There was
also an inverse correlation between SDS-extracted Ab and CREB protein levels in Alzheimer’s post-mortem
hippocampal samples. The levels of CREB-regulated BDNF and BIRC3, a caspase inhibitor, decreased and the active
cleaved form of caspase-9, a marker for the intrinsic pathway of apoptosis, was elevated in these samples. Exposure
of rat primary hippocampal neurons to Ab fibrils decreased CREB promoter activity. Decrease in CREB mRNA levels
in Ab-treated neurons was reversed by the antioxidant, N-acetyl cysteine. Overexpression of CREB by adenoviral
transduction led to significant protection against Ab-induced neuronal apoptosis.
Conclusions: Our findings suggest that chronic downregulation of CREB-mediated transcription results in decrease
of CREB content in the hippocampal neurons of AD brain which may contribute to exacerbation of disease
progression.
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Background
Cyclic AMP response element binding protein (CREB) is
a constitutively expressed nuclear transcription factor
that regulates the expression of genes involved in neuro-
nal survival and function [1-3]. CREB is essential for the
formation and retention of memory in several species
[4,5]. CREB-mediated gene expression is increased in
the hippocampus during LTP [6]. Spatial learning defi-
cits in rats are observed after intra-hippocampal infusion
of CREB antisense oligos [7]. CREB is also an important
nuclear target that couples neurotrophin-mediated
signaling to neuronal survival [8]. CREB undergoes
phosphorylation at serine 133 in response to multiple
signaling pathways [9,10]. The phosphorylated form of
CREB binds to the coactivators, CREB binding protein
(CBP) and p300 resulting in the facilitation of target
gene expression [11]. We have reported that IGF-I
induces CREB-regulated expression of the anti-apoptotic
gene, bcl-2 through multiple signaling pathways [12,13].
Previous studies have reported that CREB-mediated
gene expression is impaired in Alzheimer’s brain. The
active form of p90RSK, a critical CREB kinase, is
decreased in a transgenic rat AD model [14]. Gong et al
[15] reported a decrease in the levels of phosphorylated
CREB in hippocampal neurons of PS1/APP double
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mutant transgenic mice. Treatment of these mice with
rolipram, a phosphodiesterase inhibitor that increases
CREB phosphorylation results in a significant improve-
ment in cognitive function. In AD post-mortem brain,
there is a decrease in the levels of CREB-regulated
BDNF [16]. In cultured neurons, Ab interferes with
CREB activation by cAMP and BDNF [17-19]. However,
paradoxical CREB activation in conditions associated
with AD is also reported [20,21]. We demonstrated that
lipid peroxidation products increase the levels of active
phosphorylated form of CREB without a parallel
increase in CREB-mediated gene expression [22]. We
also reported oxidative stress-induced downregulation of
CREB-dependent bcl-2 expression in cultured rat hippo-
campal neurons [23]. In the same study, we showed that
hydrogen peroxide decreases CREB protein levels in
neurons which were normalized by preincubation with
the antioxidant, N acetyl cysteine. The objective of the
present study was to determine the expression of CREB
in three different models of AD, namely the Tg2576
mouse which expresses human APP with the Swedish
mutation, AD post-mortem brain and cultured rat hip-
pocampal neurons exposed to Ab.
Results
Laser capture microdissection (LCM) reveals decrease of
CREB mRNA in hippocampal neurons of Tg2576 mouse
brain
CREB, a constitutively expressed nuclear transcription
factor, is activated by phosphorylation at serine 133. We
have previously reported that CREB expression itself is
downregulated in cultured rat hippocampal neurons
exposed to hydrogen peroxide [23]. The objective of the
current study was to determine if oxidative stress gener-
ated in vivo in Tg2576 mouse brain decreases CREB
expression. As hippocampus consists of neuronal as well
as glial cells, LCM was performed to determine the
expression of CREB specifically in hippocampal neurons
(Figure 1A). Following amplification of RNA isolated
from captured hippocampal neurons, the mRNA levels
of CREB and its target BDNF were determined by real
time RT-PCR analysis using Taqman probes. There was
a 33% decrease in the mRNA levels of CREB in hippo-
campal neurons of Alzheimer’s mouse brain (Figure 1B).
Similarly, 38% decrease in the expression of BDNF was
also observed (Figure 1C). The promoter for BDNF con-
tains cyclic AMP response elements and is positively
regulated by CREB.
Decrease in CREB protein levels of Alzheimer’s mouse
hippocampal neurons
Western blot analysis of CREB and correction of band
intensities with b actin levels showed 40% decrease (p <
0.01) in Tg2576 mouse hippocampus as compared to
control samples (Figure 2A and 2B). The levels of
synaptophysin, a neuronal protein, did not change sig-
nificantly between the two groups. When CREB intensi-
ties were corrected for synaptophysin levels significant
decrease (p < 0.01) was observed. Immunohistochemical
staining of brain sections for CREB revealed gradual
decrease (p < 0.05) in CREB protein with aging from 9
to 19 months in both groups of mice. More pronounced
decreases were observed in all the age groups of Tg2576
mice. The images for the dentate gyrus region alone are
presented (Figure 2C). Quantitation of CREB signals in
hippocampal neurons by ImagePro analysis revealed 23-
32% decrease of CREB levels in Tg2576 mouse hippo-
campal neurons at 9, 15, and 19 months of age when
compared to nontransgenic mice at respective ages (Fig-
ure 2C). These findings further confirmed that CREB
expression is decreased in the hippocampal neurons of
Alzheimer’s mouse brain and suggested the roles of Ab
deposition and aging.
Markers of oxidative stress in Tg2576 mouse brain
Oxidative stress could be one of the potential causes of
decreased CREB expression observed in Alzheimer’s
mouse brain. We have previously reported that CREB
expression is decreased in cultured rat hippocampal
neurons exposed to hydrogen peroxide which is pre-
vented when the neurons are pretreated with the antiox-
idant, N-acetyl cysteine [23]. Therefore, we examined
the mouse brain samples for the presence of markers of
oxidative stress. Ab deposition is known to generate free
radicals in AD brain resulting in lipid peroxidation. One
such unsaturated aldehyde is 4-hydroxynonenal (HNE).
Increased staining for HNE was seen in the regions of
Ab deposition in Tg2576 mouse brain (Figure 3A). Pro-
tein bound HNE levels also increased in these samples
as shown by increases in the intensities of multiple
bands in the Western blot analysis (Figure 3B). Dual
immunohistochemical analysis showed colocalization of
malondialdehyde (MDA), another marker for oxidative
stress, stained with DAB (arrows) around NovaRed-
stained Ab deposits (Figure 3C). Astrocytosis as seen in
AD is also likely to contribute to the generation of oxi-
dative stress through cytokine release [24]. Therefore,
mouse brain sections were double-immunostained for
GFAP, a marker for astrocyte with NovaRed and for
MDA with DAB (Figure 3D). Increase in MDA levels
were seen around astrocytes as shown with a represen-
tative image. These observations suggest a pro-oxidative
environment in AD brain that is likely to cause CREB
downregulation. Next, double immunostaining for
GFAP (astrocyte) and CREB was carried out and a
representative image is shown in Figure 3E. Decreases in
CREB content were associated with abundance of GFAP
in Tg2576 mouse brain. ImagePro analysis of CREB
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Figure 1 Laser capture microdissection (LCM) of hippocampal neurons from Tg2576 mouse brain. Brain sections (10 μM) from Tg2576
transgenic mice along with nontransgenic controls were stained using HistoGene™ Stain, (Arcturus) to identify the neurons. (A) LCM was
performed to selectively capture the neurons in CA1, CA3 and dentate gyrus regions onto Capsure LCM macro caps. Captured cells were
processed for RNA isolation, RNA amplification and RT-PCR analysis. The mRNA levels of CREB (B) and its target BDNF (C) decreased in Tg2576
hippocampal neurons. *p < 0.01 compared to nontransgenic control.
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Figure 2 CREB protein levels in hippocampal neurons of mouse brain. (A) Western blot analyses of CREB and synaptophysin were carried
out with mouse hippocampal samples from 15-19 month old nontransgenic (Ntg) and Tg2576 mice. The blots were reprobed for b Actin. (B)
The band intensities were quantitated by scanning. * p < 0.01 vs nontransgenic. (C) Hippocampal sections from Tg2576 mice of different ages
were immunostained for CREB. Representative images from dentate gyrus regions are presented. (D) The intensities of CREB stain in
hippocampal neurons of different regions were quantitated by ImagepPro analysis. * p < 0.05 vs nontransgenic control of 9 month old mice. **
p < 0.01 compared to nontransgenic control at respective age.
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Figure 3 Markers of oxidative stress in Alzheimer’s mouse brain. (A) Brain sections of 15-17 month old nontransgenic (Ntg) and Tg2576
mice were immunostained for HNE with NovaRED and counterstained with methyl green. (B) Western blot analysis of mouse brain samples for
protein bound HNE was performed. (C) Double immunostaining of mouse brain sections was carried out with monoclonal antibodies to Ab
(4G8) and polyclonal antibody for MDA. The chromogens were NovaRED for Ab and DAB for MDA. (D) Double immunostaining of mouse brain
sections was carried out with monoclonal antibody to GFAP (NovaRED) and polyclonal antibody to MDA (DAB). (E) Double immunostaining was
performed with monoclonal antibody to GFAP (NovaRED) and polyclonal antibody for CREB (DAB). Representative images are provided. Markers
of oxidative stress were elevated in Tg2576 mouse brain.
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content in multiple fields further showed a mean
decrease of 42% (p < 0.001) in high GFAP areas of
Tg2576 mouse cortex as compared to low GFAP areas
in nontransgenic mouse brain. These observations sug-
gest a potential relationship between oxidative stress
and CREB downregulation.
Inverse correlation between Ab deposition and CREB
content
Having observed downregulation of CREB expression in
Tg2576 mouse brain, next we examined AD post-mor-
tem samples to determine the levels of CREB. Western
blot analysis showed decrease of CREB content in AD
hippocampal samples when compared to age-matched
controls (Figure 4A). Phosphorylated form of CREB also
decreased significantly in AD brain which is likely to be
the result of decrease in the levels of CREB protein
itself. Quantitation of band intensities revealed a 52%
decrease in CREB levels in AD hippocampi (Figure 4B).
We also determined the levels of Ab (1-42) in the post-
mortem samples using a sandwich ELISA. There was a
257% increase in the levels of soluble Ab in AD hippo-
campal samples (Figure 4C). In the case of SDS-extrac-
table Ab (1-42), the increase was significantly more
(505%; Figure 4D). When SDS-soluble Ab levels were
plotted against CREB band intensities, significant (p <
0.001) inverse relationship between the two was
observed with a correlation co-efficient of 0.78 (Figure
4E) suggesting that Ab deposition may lead to decrease
in CREB content in AD brain. No significant correlation
between soluble Ab and CREB levels was observed
(results not shown).
Decreased expression of CREB-regulated proteins and
markers of oxidative stress in AD brain
Next we examined the expression of a panel of CREB-
dependent proteins that are involved in neuronal func-
tion and survival. Significant decreases in AD brain were
observed for BDNF (31%; p < 0.01), Bcl-2 (23%; p <
0.05), BIRC3 (44% p < 0.01) and BIRC4 (32%; p < 0.01)
when compared to age-matched controls (Figure 5). Bcl-
2 is an anti-apoptotic protein that maintains the integ-
rity of mitochondrial membrane. BIRC3 (c-IAP2) and
BIRC4 (XIAP) are caspase inhibitors that play important
roles in neuronal survival. In addition, the levels of
proapoptotic Bax increased by 38% (p < 0.05), probably
as a result of oxidative stress. Modulation of proteins in
apoptosis pathway, together, resulted in 150% increase
in the levels of active cleaved form of caspase-9, a mar-
ker for the intrinsic pathway of apoptosis. Markers of
oxidative stress were also examined with post mortem
samples. Increases in the levels GFAP (astrocyte) and
protein-bound HNE were observed in AD brain (Figure
6A). Furthermore, Oxyblot analysis showed increases in
the intensities of multiple bands (Figure 6B) suggesting
accumulation of oxidized proteins in AD brain.
Ab-induced decrease in CREB expression in cultured rat
hippocampal neurons
Although there was correlation between accumulation of
oxidative stress markers and decrease of CREB content
in Tg2576 mouse brain and AD post-mortem brain,
these findings do not suggest a causal relationship
between the two. Therefore, we used cultured rat hippo-
campal neurons to determine the effects of Ab aggre-
gates on CREB expression. Preincubation of neurons
with Ab fibrils resulted in 40-50% decrease in the activ-
ity of CREB-responsive BDNF promoter (p < 0.01) (Fig-
ure 7A) and CREB-promoter (p < 0.05) (Figure 7B).
Although oligomers decreased BDNF promoter activity
(p < 0.05), it had no effect on CREB promoter. Exposure
of hippocampal neurons to Ab fibrils led to generation
of reactive oxygen species as shown by the fluorescence
of oxidation-sensitive dye (Figure 7C). Ab treatment
also caused 40% decrease (p < 0.01) in CREB mRNA
levels and pretreatment with the antioxidant NAC pre-
vented this decrease (Figure 7D). Similar findings were
obtained for CREB protein as shown by the Western
blot analysis (Figure 7E). The promoter for CREB itself
contains CRE sites. Therefore persistent decrease in
CREB activity by Ab fibril-generated oxidative stress
could lead to decrease of CREB content itself. To deter-
mine if oxidative stress plays a role in Ab-induced neu-
ronal apoptosis, the antioxidant enzyme MnSOD was
overexpressed in rat hippocampal neurons. A chimeric
gene consisting of MnSOD and GFP was used in the
transfection to identify the neurons expressing this
enzyme. The neurons expressing MnSOD were pro-
tected from Ab as shown by significant absence of active
caspase-9 staining among GFP-expressing neurons (Fig-
ure 7F).
CREB-mediated protection of rat hippocampal neurons
from Ab-induced apoptosis
To test our hypothesis that CREB is a neuroprotective
factor, we tested Ab toxicity in rat hippocampal neurons
following modulation of CREB function by plasmid
transfection. The wild-type or dominant negative
mutant forms of CREB were introduced into cultured
neurons along with GFP (to identify the transfected
cells; Figure 8A). The transfected neurons were then
exposed to Ab fibrils and apoptotic cells were counted
among green cells (Figure 8B). GFP expression did not
affect apoptosis induced by Ab fibrils because nuclear
condensation was observed randomly among neurons
with and without GFP. Counting of ~500 GFP-expres-
sing neurons showed 64% decrease in apoptotic cells
when wild-type CREB was overexpressed. In the case of
Pugazhenthi et al. Molecular Neurodegeneration 2011, 6:60
http://www.molecularneurodegeneration.com/content/6/1/60
Page 6 of 16
Figure 4 Decrease in CREB protein in AD-postmortem brain. (A) Post-mortem hippocampal samples (12 each) of AD cases and age-matched
controls with equal protein content were electrophoresed, transferred, and immunoprobed with antibodies to CREB, phospho CREB (PCREB) and
b actin. Representative blots are shown. (B) Band intensities of CREB and PCREB were quantitated and corrected for b actin for 24 samples. Total
and phospho CREB levels were significantly low in AD brain. *P < 0.01 compared to control. (C, D) Ab 1-42 levels were determined in soluble
and SDS-extractable fractions of post-mortem samples by sandwich ELISA. Elevated levels of soluble and SDS-extractible Ab were observed in AD
brain. *p < 0.01; **p < 0.001 vs control. (E) When the levels of SDS-soluble Ab were plotted against CREB band intensities, an inverse correlation
between the two parameters was observed. Control values are shown as open squares and AD values as filled squares.
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neurons expressing dominant negative mutant forms of
CREB, Ab-induced neuronal death was exacerbated by
81% (KCREB) and 89% (MCREB). The gene transfer effi-
ciency was moderate (25%-35%) by plasmid transfection
in this experiment. Even though we used GFP to iden-
tify transfected cells, we sought a more efficient gene
transfer method. We used adenoviral gene delivery sys-
tem to modulate CREB function more efficiently in neu-
rons. First, we tested the efficiency of gene transfer in
hippocampal neurons. CREB staining was significantly
higher in neurons transduced with adenoviral wild-type
CREB (Figure 8C). Western blot analysis showed a 3-
fold increase in CREB levels (Figure 8D). Next, the neu-
rons transduced with adenoviral b gal (control) CREB,
KCREB and MCREB were exposed to Ab fibrils and the
activity of caspase-9, a marker for the intrinsic mito-
chondrial pathway of apoptosis was determined (Figure
8E). Adenoviral b gal did not significantly increase the
basal caspase-9 activity seen in neurons that were not
transduced with a viral vector. Transduction of neurons
Figure 5 Markers of CREB function and apoptosis in AD-post mortem brain. Post-mortem hippocampal samples (8 each) of AD cases and
age-matched controls with equal protein content were electrophoresed, transferred, and immunoprobed with antibodies for markers of CREB
function and apoptosis. The blots were reprobed for b actin. Representative images are provided. Decreases in CREB-regulated proteins that
improve neuronal survival and increases in the levels of the active form of caspase-9, a marker for the intrinsic pathway of apoptosis were
observed in AD-post mortem brain.
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with wild type CREB resulted in 42% decrease in cas-
pase-9 activity whereas downregulation with two mutant
forms of CREB resulted in exaggeration of caspase-9
activation by 140-170%. These observations suggest that
the preservation of CREB function is essential to protect
hippocampal neurons from Ab-induced injury.
Discussion
CREB is a constitutively expressed nuclear transcription
factor needed for cognition and neuronal survival. Its
regulation is primarily through phosphorylation at serine
133 by several signaling kinases and thus responds to a
variety of extracellular signals [10,13,25,26]. CREB-regu-
lated gene expression has been shown to be downregu-
lated in AD brain. In this study, we show that the
expression of CREB itself is decreased in Tg2576 mouse
hippocampal neurons, AD post-mortem hippocampal
samples and in Ab-treated rat hippocampal neurons.
Our findings suggest that persistent downregulation of
CREB-regulated gene expression could lead to decrease
in the levels of CREB itself which could exacerbate neu-
rodegeneration in AD.
Tg2576 mice overexpressing human APP with the
Swedish mutation are characterized by Ab deposition
and cognitive dysfunction [27,28]. Previous studies have
suggested that markers of CREB function are downregu-
lated in the hippocampal neurons of this mouse model
[14,15,29]. We demonstrate in the present study by laser
capture microdissection (LCM) that the levels of CREB
mRNA are significantly decreased in the hippocampal
Figure 6 Markers of oxidative stress in AD-post mortem brain. (A) Post-mortem hippocampal samples (8 each) of AD cases and age-
matched controls with equal protein content were immunoblotted for GFAP and HNE, markers of oxidative stress. Representative images are
provided. There was accumulation of markers of oxidative stress in AD brain. (B) Post-mortem samples were treated with 2,4-
dinitrophenylhydrazine (DNPH) to form DNP-hydrazone. DNP-derivatized protein samples were electrophoresed and immunoblotted with anti-
DNP antibody. Oxidative modification of proteins was elevated in AD brain samples.
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Figure 7 Effects of Ab oligomers and fibrils on CREB expression in cultured rat hippocampal neurons. (A, B) Hippocampal neurons were
transfected with luciferase reporters linked to a BDNF promoter (A) or a CREB promoter (B) with LipofectAMINE 2000 reagent. A constitutively
active renilla luciferase was also included for transfection efficiency. Transfected cells were treated with Ab oligomers or fibrils (2 μM) for 24 h.
Luciferase activities were determined using dual luciferase assay kit (Promega). Oligomers decreased the activity of BDNF-promoter but not CREB
promoter whereas fibrils downregulated both promoters. *p < 0.05 and **p < 0.01 compared to untreated control. (C) Intracellular oxidative
stress was measured using an oxidation-sensitive dye, 5- (and 6-)-chloromethyl-2’, 7’-dichlorodihydrofluorescein diacetate (CM-H2DCFDA). Rat
primary hippocampal neurons were loaded with the dye and the fluorescence emitted at 535 nm was measured using the CytoFluor multiwell
plate reader after exposure to Ab fibrils (2 μM). Ab fibrils induced significant accumulation of reactive oxygen species in neurons. **p < 0.001 vs
control. (D) Neurons were exposed to Ab fibrils (2 μM) in the presence and absence of N-acetyl cysteine (NAC; 5 mM) for 18 h. Total RNA was
isolated and the levels of CREB mRNA were measured by real-time quantitative RT-PCR using a TaqMan™ fluorogenic probe. The values are
mean ± SEM of four independent experiments. Ab-induced downregulation of CREB expression was blocked by the antioxidant, N-acetyl
cysteine. *p < 0.01 compared to control and #p0.01 vs Ab. (E) Neurons were exposed to Ab fibrils (2 μM) in the presence and absence of N-
acetyl cysteine (NAC; 5 mM) for 18 h. Treated neurons were lysed and processed for the Western blot analysis of CREB and b actin. NAC restored
Ab-induced decrease in CREB protein levels. (F) Hippocampal neurons cultured on cover slips were transfected with plasmids encoding GFP or
MnSOD-GFP chimeric protein (green) followed by exposure to Ab (5 μM) for 48 h. The fixed cells were immunostained for the active cleaved
fragment of Caspase-9 with Cy-3 (red) as a marker for the mitochondrial pathway of apoptosis. Examination of 20 fields each from 3
independent experiments showed that the cells expressing MnSOD (green) were resistant to Ab-induced apoptosis.
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Figure 8 Neuroprotective effects of CREB. (A) Rat primary hippocampal neurons cultured on cover slips were transfected with green
fluorescent protein (GFP) alone or in combination with wild type CREB or its mutants (KCREB or MCREB). The transfected neurons were exposed
to Ab (5 μM) for 48 h. The apoptotic cells are identified by nuclear condensation with DAPI (Blue). (B) Apoptosis among GFP expressing cells
was quantitated by counting neurons with condensed nuclei. At least 500 GFP expressing cells were examined. Neurons were protected by
CREB expression and CREB mutants exacerbated Ab toxicity. *p < 0.01 compared to GFP control. (C) Rat primary hippocampal neurons cultured
on cover slips were transduced with recombinant adenoviruses (AdV) encoding b galactosidase (b gal; control) or wild-type CREB (M.O.I: 50) for
48 h. The neurons were fixed, permeabilized, and immunostained for MAP2a (neurites) with FITC (green) and for CREB with Cy3 (red). (D) In
addition, cultured rat primary hippocampal neurons were transduced with adenoviral b gal or CREB for 48 h. The whole cell lysates were
prepared and immunoblotted for CREB and b galactosidase. Significant upregulation of CREB expression was seen following adenoviral
transduction. (E) Cultured rat primary hippocampal neurons were transduced with adenoviruses encoding b galactosidase (b gal), wild type CREB
(WT-CREB) or dominant negative mutant forms of CREB (KCREB or MCREB). After 24 h, neurons were exposed to 5 μM of Ab fibrils for 48 h and
then the activity of caspase-9, a marker for the intrinsic pathway of apoptosis was assayed. Significant protection of neurons from Ab-induced
apoptosis was observed. *p < 0.01 vs b galactosidase control.
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neurons of Tg2576 mouse brain (Figure 1). The expres-
sion of BDNF, a target gene of CREB was also found to
be reduced in LCM-captured neurons. Further examina-
tion of CREB protein by immunohistochemical analysis
showed age-dependent decreases in hippocampal neu-
rons, more significantly in the transgenic mouse brain
(Figure 2). Markers of oxidative stress including HNE
and MDA were also elevated. We observed decreases in
CREB levels especially in the regions where astrocytes
were abundantly present (Figure 3E). Astrocytosis is
known to play a role in neurodegeneration through
release of cytokines [30,31]. We have previously
reported in cultured MIN6 cells, a mouse pancreatic cell
line that a combination of proinflammatory cytokines,
IL-1b, TNF-a and IFN-g decreases CREB expression fol-
lowing chronic exposure [32].
Oxidative stress is known to play an important role in
the neurodegenerative process of Alzheimer’s brain.
Accumulation of free radicals is an important feature of
aging, which is also a risk factor for AD. Markers of oxi-
dative stress are found in aged rats, especially in those
with impaired spatial learning [33]. Hensley et al.
demonstrated that Ab aggregation leads to generation of
oxidative stress in vitro [34,35]. In addition, several
other agents, including iron, aluminum, and advanced
glycosylation end products, induce oxidative stress in
AD [36-38]. Lipid peroxidation and DNA oxidation pro-
ducts accumulate in AD brains as a result of oxidative
stress [36,39-41]. We observed increased protein-bound
HNE and protein oxidation in AD post-mortem samples
as shown by Oxyblot analysis (Figure 6). SDS-extractable
Ab accumulation showed inverse correlation with CREB
levels in AD post-mortem brain (Figure 4E). These find-
ings suggest that Ab-generated oxidative stress could
play a role in downregulation of CREB expression. To
determine the direct effects of Ab on CREB expression
we examined the activity of a luciferase reporter gene
driven by the CREB promoter in cultured rat hippocam-
pal neurons. CREB promoter activity was downregulated
by Ab fibrils but not by Ab oligomers (Figure 7B). The
oligomers did decrease the activity of CREB-dependent
BDNF promoter activity (Figure 7A). Furthermore, Ab
fibril-induced decrease in CREB mRNA levels was pre-
vented by preincubation of neurons with the antioxi-
dant, NAC (Figure 7D). Thus our findings with cultured
hippocampal neurons provide direct evidence for the
downregulation of CREB expression by oxidative stress.
Although Ab oligomers did not play a role in the down-
regulation of CREB expression in this study, their role
in AD pathology is well characterized.
Several reports have shown that caspase activation, a
marker of apoptosis, is observed in the neurons in AD
brain (reviewed in [42]). Caspase activation can also play
a role in AD pathology independent of causing neuronal
death. For example, caspase-cleaved tau undergoes con-
formational changes that facilitate filament formation,
and Ab localizes to cleaved tau [43]. Although signifi-
cant loss of neurons is observed in human AD brain,
marked neuronal apoptosis is not observed in mouse
models of AD. We observed modulation of several pro-
teins in the apoptosis pathway in AD post-mortem
brain (Figure 5). The levels of anti-apoptotic Bcl-2 and
caspase inhibitors, BIRC3 and BIRC4 decreased and
proapoptotic Bax increased in AD brain leading to acti-
vation of caspase-9, a marker for the intrinsic pathway
of apoptosis. CREB plays an important role in increasing
the levels of proteins that maintain mitochondrial mem-
brane integrity and prevent the release of cytochrome c,
an activator of caspase-9. Oxidative stress is known to
induce neuronal apoptosis by a dual mechanism of
downregulation of anti-apoptotic genes and upregulation
of proapoptotic genes [44].
We have previously reported that IGF-I induces
CREB-mediated bcl-2 expression in PC12 cells through
multiple signaling pathways [12,13]. We also reported
that oxidative stress downregulates bcl-2 expression in
rat hippocampal neurons [23]. In the present study, we
observed that Ab-induced neuronal apoptosis is exag-
gerated when dominant negative mutant forms of CREB
(KCREB and MCREB) were overexpressed along with
GFP by plasmid transfection (Figure 8A). KCREB is
mutated at the DNA binding region of CREB. This
mutant will heterodimerize with endogenous CREB and
sequester it away from target promoters. MCREB is
mutated at the critical phosphorylation site (S133A).
MCREB will bind to CRE but cannot bind to the coacti-
vators. We also tested the effects of modulation of
CREB function by adenoviral transduction on Ab toxi-
city (Figure 8E). Apoptosis by the intrinsic pathway was
induced by Ab as shown by the activation of caspase-9
as observed in AD post-mortem brain (Figure 5).
Expression of wild type CREB decreased neuronal death
induced by Ab significantly. There was also exacerbation
of Ab-induced apoptosis when the neurons were trans-
duced with adenoviral KCREB or MCREB. Thus chronic
CREB downregulation caused by oxidative stress could
be an important cause of loss of neurons in AD brain.
Conclusions
The primary events occurring in the pathogenesis of AD
include the deposition of Ab-containing senile plaques
and the formation of neurofibrillary tangles. This trig-
gers a slow neurodegenerative process involving multiple
insults to neurons, including free radical generation and
inflammatory responses. During this slow progressive
phase, the cellular defense mechanism fails, due to oxi-
dative stress-induced changes in transcriptional events
including downregulation of CREB expression. In the
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treatment of AD, downstream interventions cannot be
discounted as it is essential to repair neuronal injury
while attempting to help clear Ab accumulation. Small
molecule enhancers of CREB-mediated gene expression
are being considered as potential therapeutic agents in
the treatment of AD [45].
Methods
Materials
Cell culture media and supplies were purchased from
Gemini BioProducts (Woodland, CA, USA) and Invitro-
gen-Life Technologies (Carlsbad, CA). Antibodies to
CREB, phosphorylated form of CREB, synaptophysin,
BIRC3, BIRC4, Bax, active caspase-9, GFAP, and b actin
were from Cell signaling (Beverly, MA). The antibodies
to HNE and MDA and caspase-9 assay kit were
obtained from Millipore (Billerica MA). The cDNA
encoding a chimeric protein for GFP and MnSOD was
provided by Dr. Sonia Flores (University of Colorado,
Aurora, CO). IgG linked to Cy3 or FITC were obtained
from Jackson ImmunoResearch (West Grove, PA, USA).
All other fine chemicals were from Sigma (St. Louis,
MO). We obtained 24 post-mortem samples (12 each of
control and AD) from the AD Brain bank at University
of Colorado. The mean age was 75 y for AD and 73 y
for controls. The postmortem delay (PMD) was 3-12 h
(mean 7 h). This is comparable to PMD reported in
other studies [46-49]. The groups of subjects were char-
acterized as AD or normal controls using the criteria
from the Consortium to Establish a Registry for AD
[50].
Laser capture microdissection of mouse hippocampal
neurons
All animal procedures were performed with the approval
of the Subcommittees on Research Safety and Institu-
tional Animal Care and Use at the Denver Department
of Veterans Affairs Medical Center, Eastern Colorado
Health Care System (ACORP# 08006M). Tg2576 mice
and nontransgenic controls were anesthetized and per-
fused with cold RNase-free phosphate buffered saline.
The brain was removed and embedded in Tissue-TeK
OCT in a plastic mold and frozen. Frozen brain sections
(10 μM) were cut on a cryostat and collected on Super-
frost slides (Fischer Scientific, Pittsburgh, PA). DEPC-
treated water was used in all procedures. All solutions
except wash buffers contained 0.5 U/μl RNase inhibitor.
Brain sections (10 μM) were stained using HistoGene™
Stain, (Arcturus) to identify the neurons. LCM was per-
formed using AutoPix LCM system from Arcturus Engi-
neering (Mountain View, CA). The neurons in CA1,
CA3 and dentate gyrus regions were selectively captured
from each section onto Capsure LCM macro caps. Total
RNA was isolated from LCM samples using a PicoPure
RNA isolation kit (Arcturus). Because the RNA yield is
low, additional amplification steps were used following
the RiboAMP RNA amplification kit instructions from
Arcturus. Real time RT-PCR analysis using Taqman
probes was performed for mouse neurofilament heavy
chain (mNFHc) to determine the neuronal nature of the
samples and human APP to differentiate the RNA sam-
ples isolated from nontransgenic and APP transgenic
mice. In addition, the mRNA levels of CREB and BDNF
were compared in amplified RNA samples from non-
transgenic and transgenic mice. The PCR reactions in
96 wells were monitored in real time in an ABI Prism
7700 sequence detector (Perkin Elmer Corp./Applied
Biosystems).
Immunohistochemical analysis of Tg2576 mouse brain
The tissue sections were de-paraffinized and hydrated
through serial dilutions of ethanol and then in distilled
water. The hydrated sections were steamed in 10 mM
sodium citrate buffer (pH 6.0) for 30 min for antigen
retrieval. They were treated with 1% hydrogen peroxide
for 10 min and blocked with 5% horse serum for 1 h at
RT. Subsequently, depending on whether the antibody
was from mouse or rabbit, we used a ‘mouse on
mouse’ or rabbit ABC elite kit from Vector labora-
tories (Burlingame, CA), respectively. The chromogens
were Novared and/or DAB. Counterstaining was with
methyl green. For double immunostaining, color was
developed with the first primary antibody followed by
incubation with the second antibody and color
development.
Western blot analysis
Proteins were resolved by SDS-PAGE electrophoresis,
transferred to polyvinylidene difluoride membranes and
blocked with 5% non-fat dry milk for 1 h at RT. The
membranes were exposed to primary antibodies at a
dilution of 1:1000 overnight at 4°C. After washing with
5% non-fat milk, the membranes were incubated in the
presence of appropriate secondary antibodies linked to
alkaline phosphatase for 1 h at RT. After treating with
alkaline washing buffer (10 mM Tris-HCl (pH 9.5), 10
mM NaCl and 1 mM MgCl2), signals were developed
with CDP-Star reagent (New England Biolabs, Beverly,
MA) and exposed to X-ray film. The intensity of bands
were measured by using Fluor-S MultiImager and
Quantity One software (Bio-Rad, Hercules, CA) and cor-
rected for the levels of b actin. Oxyblot analysis: Oxida-
tive modification of proteins by free radicals was
determined for AD-post mortem samples along with
age-matched controls using a kit from Millipore (Biller-
ica, MA). The protein samples (20 μg) in 5 μl were
mixed with 5 μl of 12% SDS for a final concentration of
6% and derivatized with 10 μl of 1X DNPH solution.
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The samples were incubated at RT for 15 min, neutra-
lized and electrophoresed. Following transfer, the blots
were immunoprobed with anti-DNP antibody and the
signals were developed with CDP-Star.
Ab assay and preparation of Ab aggregates
After extracting the soluble fractions from post-mortem
samples with Tris-buffered saline (pH 7.6) containing
1% Triton X-100 and protease inhibitors, the tissue pel-
lets were extracted with 2% SDS containing protease
inhibitors. The extracts were appropriately diluted and
Ab 1-42 levels were determined by sandwich ELISA. For
capture, the Ban-50 (1-42) antibody was used and the
BC-05 antibody was used for detection. To determine
Ab-induced toxicity in cultured neurons, Ab aggregates
were prepared by the following procedure: Ab (1-42)
peptide purchased from Peptide 2.0 (Chantilly, VA) was
first monomerized by resuspending in hexafluoroisopro-
panol followed by incubation at RT for 1 h. After eva-
poration of solvent under vacuum, Ab is dissolved in
DMSO and stored at -20°C. Ab oligomer stock (100
μM) was prepared by incubation in F-12 (without phe-
nol red) culture medium at 4°C for 24 h. Ab fibril stock
(100 μM) was prepared by incubation in HCl (10 mM)
at 37°C for 24 h.
Culture of rat hippocampal neurons and transfection
Hippocampal neurons were isolated from E18 rat
embryos obtained from timed-pregnant Sprague-Daw-
ley rats as previously described [51]. The astrocyte
population was less than 5%. The neurons were cul-
tured in serum-free Eagle’s medium containing 2%
antioxidant-free B27 supplement (Life Technologies).
The experiments were carried out in these neurons
after one week in culture [22]. Total RNA was isolated
from treated neurons using an isolation kit (Versagene
RNA; Fisher Scientific, Pittsburgh, PA). Transient
transfection of rat hippocampal neurons cultured in
12 well dishes to about 70% confluence was per-
formed using LipofectAMINE 2000 reagent (Invitro-
gen-Life Technologies) according to the procedure
described previously [22]. BDNF promoter and CREB
promoter linked to a luciferase reporter gene were
provided by Anne West (Harvard Medical School,
Boston) and Dr. Dwight Klemm (University of Color-
ado) respectively. A constitutively active renilla luci-
ferase (pRL-TK-luc) was included to correct for
transfection efficiency and nonspecific actions of oxi-
dative stress. After 6 h of transfection, the neurons
were exposed to Ab oligomers or fibrils for 18 h. The
cells were processed for the assay of luciferases using
dual luciferase assay kit (Promega). The transfection
efficiency for rat hippocampal neurons using Lipofec-
tAMINE 2000 reagent was ~30%.
Immunocytochemistry
Rat hippocampal neurons were cultured on glass cover
slips (Carolina Biological Supply, Burlington, NC) pre-
pared according to the methods of Goslin and Banker
[52]. Treated neurons were fixed in 4% paraformalde-
hyde for 30 min at RT and washed with PBS. The cells
were permeabilized in PBS containing 0.2% Triton X-
100 and 5% BSA for 90 min at RT, followed by incuba-
tion with the primary antibody at 4°C overnight. Double
immunostaining was performed using monoclonal and
polyclonal antibodies for two targets. After washing with
PBS, appropriate secondary antibodies linked to Cy3
and FITC were added along with DAPI (2 μg/ml;
nuclear staining) for 90 min at RT. The cells were then
washed in PBS, mounted on slides and examined by
digital deconvolution microscopy.
Measurement of intracellular oxidative stress
Intracellular ROS (reactive oxygen species) generation
was measured in neurons exposed to Ab aggregates
using an oxidation-sensitive dye, 5- (and 6-)chloro-
methyl-2’,-7’-dichlorodihydrofluorescein diacetate (CM-
H2DCFDA). When the cells are loaded with this dye, its
acetate groups are cleaved by cellular nonspecific
esterases, trapping the dye in the cell. Although this
“leuco” form of the dye is colorless, the oxidized dye
fluoresces at 535 nm when excited with 485 nm light.
The cells were loaded with the dye and the fluorescence
was measured using the CytoFluor multiwell plate
reader.
Caspase-9 assay
Cultured rat hippocampal neurons transduced with ade-
noviruses followed by exposure to Ab fibrils were pro-
cessed for the assay of caspase-9 using a kit from
Millipore (Billerica, MA). Supernatant of the cell lysates
were incubated in the presence of substrate, p-nitroani-
lide-labeled LEHD. The released chromophore was read
at 405 nm using a microplate reader.
Statistical analysis
Data presented are Mean ± SE. Statistical evaluation was
performed by one-way ANOVA with Dunnett’s multiple
comparison test.
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